OTCMKTS:HRIBF - Horiba Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $53.15 0.00 (0.00 %) (As of 02/19/2019)Previous Close$53.15Today's Range$53.00 - $53.1552-Week Range$46.50 - $69.00Volume200 shsAverage VolumeN/AMarket Capitalization$2.24 billionP/E RatioN/ADividend YieldN/ABeta0.7 ProfileDiscussionChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email HORIBA, Ltd. provides a range of instruments and systems for automotive research and development (R&D), process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing, metrology, and scientific R&D and QC measurement applications. Its Automotive Test Systems segment offers emission measurement systems, in-use automotive emissions analyzers, driveline test systems, engine test and brake test systems, and intelligent transport systems; and provides engineering consultancy, test services and consultancy, and research and development facility leasing services. The company's Process & Environmental Instruments & Systems segment provides stack gas analyzers, water quality analysis and examination systems, air pollution analyzers, environmental radiation monitors, and process measurement equipment. Its Medical-Diagnostic Instruments & Systems segment designs, develops, and distributes hematology analyzers, equipment for measuring immunological responses, clinical chemistry analyzers, and blood sugar measurement systems. The company's Semiconductor Instruments & Systems segment provides mass flow controllers, chemical concentration monitors, reticle/mask particle detection systems, and residual gas analyzers. Its Scientific Instruments & Systems segment offers pH meters, particle-size distribution analyzers, X-Ray fluorescence analyzers, metal analyzers, Raman fluorescence spectroscopy systems, spectrophotometers, and gratings. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan. Receive HRIBF News and Ratings via Email Sign-up to receive the latest news and ratings for HRIBF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Analytical instruments Sub-IndustryN/A SectorIndustrial Products Current SymbolOTCMKTS:HRIBF Previous Symbol CUSIPN/A CIKN/A WebN/A PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio12.96 P/E Growth1.27 Sales & Book Value Annual Sales$1.57 billion Price / Sales1.43 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares42,160,000Market Cap$2.24 billion Next Earnings DateN/A OptionableNot Optionable Horiba (OTCMKTS:HRIBF) Frequently Asked Questions What is Horiba's stock symbol? Horiba trades on the OTCMKTS under the ticker symbol "HRIBF." Has Horiba been receiving favorable news coverage? Headlines about HRIBF stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Horiba earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near term. Who are some of Horiba's key competitors? Some companies that are related to Horiba include Bruker (BRKR), Coherent (COHR), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Fluidigm (FLDM), Quanterix (QTRX), Eyepoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO), Arrayit (ARYC), HTG Molecular Diagnostics (HTGM), BioNano Genomics (BNGO), Aethlon Medical (AEMD), Scientific Industries (SCND), Pressure Biosciences (PBIO) and Precipio (PRPO). Who are Horiba's key executives? Horiba's management team includes the folowing people: Mr. Atsushi Horiba, Chairman & Group CEO (Age 71)Mr. Juichi Saito, Exec. Vice Chairman & Group COO (Age 61)Dr. Masayuki Adachi, Pres, COO & DirectorMr. Sunao Kikkawa, Sr. Corp. Officer and Gen. Mang. of Fin. & Control DivisionMasao Okawa, Sr. Corp. Officer and Gen. Mang. of Gen. Admin. Division How do I buy shares of Horiba? Shares of HRIBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Horiba's stock price today? One share of HRIBF stock can currently be purchased for approximately $53.15. How big of a company is Horiba? Horiba has a market capitalization of $2.24 billion and generates $1.57 billion in revenue each year. MarketBeat Community Rating for Horiba (OTCMKTS HRIBF)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 90 (Vote Outperform)Underperform Votes: 121 (Vote Underperform)Total Votes: 211MarketBeat's community ratings are surveys of what our community members think about Horiba and other stocks. Vote "Outperform" if you believe HRIBF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HRIBF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/26/2019 by MarketBeat.com StaffFeatured Article: How can you know how many shares are floating?